{"id":"https://openalex.org/W2891024671","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","title":"Safety and tolerability of FOLFIRABRAX [5-Fluourouracil (5-FU), irinotecan (IRI), and nab-paclitaxel (NP)] with genotype-guided dosing of IRI in previously untreated advanced gastrointestinal (GI) cancer patients (pts): A multicenter trial of the University of Chicago Personalized Cancer Care Consortium.","display_name":"Safety and tolerability of FOLFIRABRAX [5-Fluourouracil (5-FU), irinotecan (IRI), and nab-paclitaxel (NP)] with genotype-guided dosing of IRI in previously untreated advanced gastrointestinal (GI) cancer patients (pts): A multicenter trial of the University of Chicago Personalized Cancer Care Consortium.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2891024671","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","mag":"2891024671"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.e16241","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101759913","display_name":"Smita Suhas Joshi","orcid":"https://orcid.org/0000-0001-5272-2855","observed_orcids":["https://orcid.org/0000-0001-5272-2855"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Smita Suhas Joshi","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039500951","display_name":"Theodore Karrison","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Theodore Karrison","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084809433","display_name":"Daniel V.T. Catenacci","orcid":"https://orcid.org/0000-0001-7517-8020","observed_orcids":["https://orcid.org/0000-0001-7517-8020"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daniel V.T. Catenacci","raw_affiliation_strings":["University of Chicago Pritzker School of Medicine, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Pritzker School of Medicine, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004519406","display_name":"Jaclyn D Peterson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jaclyn D Peterson","raw_affiliation_strings":["University of Chicago Medical Center, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago Medical Center, Chicago, IL;","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011595369","display_name":"Mark M. Zalupski","orcid":"https://orcid.org/0000-0002-2114-9352","observed_orcids":["https://orcid.org/0000-0002-2114-9352"]},"institutions":[{"id":"https://openalex.org/I27837315","display_name":"University of Michigan","ror":"https://ror.org/00jmfr291","country_code":"US","type":"education","lineage":["https://openalex.org/I27837315"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Zalupski","raw_affiliation_strings":["University of Michigan, Ann Arbor, MI;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Michigan, Ann Arbor, MI;","institution_ids":["https://openalex.org/I27837315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019315450","display_name":"Brooke Elizabeth Phillips","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brooke Elizabeth Phillips","raw_affiliation_strings":["University of Chicago, New Lenox, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, New Lenox, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102459712","display_name":"Ahad Ali Sadiq","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ahad Ali Sadiq","raw_affiliation_strings":["Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fort Wayne Medical Oncology and Hematology, Fort Wayne, IN;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065243976","display_name":"Amikar Sehdev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4388446366","display_name":"Indiana University Indianapolis","ror":"https://ror.org/03eftgw80","country_code":"US","type":"education","lineage":["https://openalex.org/I4388446366","https://openalex.org/I592451"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amikar Sehdev","raw_affiliation_strings":["Indiana University, Indianapolis, IN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Indiana University, Indianapolis, IN;","institution_ids":["https://openalex.org/I4388446366"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047818279","display_name":"James Lloyd Wade","orcid":"https://orcid.org/0000-0002-3802-3860","observed_orcids":["https://orcid.org/0000-0002-3802-3860"]},"institutions":[{"id":"https://openalex.org/I4210118753","display_name":"Heartland Cancer Research","ror":"https://ror.org/03fg03m71","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210118753"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James Lloyd Wade","raw_affiliation_strings":["Heartland Cancer Research NCORP, Decatur, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Heartland Cancer Research NCORP, Decatur, IL;","institution_ids":["https://openalex.org/I4210118753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039034056","display_name":"Vincent J. Picozzi","orcid":"https://orcid.org/0009-0002-3493-7769","observed_orcids":["https://orcid.org/0009-0002-3493-7769","https://orcid.org/0009-0004-4604-9229"]},"institutions":[{"id":"https://openalex.org/I1317886745","display_name":"Virginia Mason Medical Center","ror":"https://ror.org/00cm2cb35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1317886745","https://openalex.org/I2802797007","https://openalex.org/I4210118434"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vincent J. Picozzi","raw_affiliation_strings":["Virginia Mason Hospital and Medical Center, Seattle, WA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Mason Hospital and Medical Center, Seattle, WA;","institution_ids":["https://openalex.org/I1317886745"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045434993","display_name":"Andrea Louise Amico","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087865","display_name":"University of Chicago Medical Center","ror":"https://ror.org/0076kfe04","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087865"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrea Louise Amico","raw_affiliation_strings":["Universtiy of Chicago Medical Center, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universtiy of Chicago Medical Center, Chicago, IL;","institution_ids":["https://openalex.org/I4210087865"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013408333","display_name":"Robert Marsh","orcid":"https://orcid.org/0000-0003-1871-096X","observed_orcids":["https://orcid.org/0000-0003-1871-096X"]},"institutions":[{"id":"https://openalex.org/I1339509835","display_name":"Endeavor Health","ror":"https://ror.org/04tpp9d61","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1339509835"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert de Wilton Marsh","raw_affiliation_strings":["Kellogg Cancer Center, NorthShore University Health System, Evanston, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Kellogg Cancer Center, NorthShore University Health System, Evanston, IL;","institution_ids":["https://openalex.org/I1339509835"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111632455","display_name":"M. Kozloff","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1328302364","display_name":"Ingalls Memorial Hospital","ror":"https://ror.org/00e7taa66","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1328302364"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Kozloff","raw_affiliation_strings":["Ingalls Memorial Hospital, Harvey, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ingalls Memorial Hospital, Harvey, IL;","institution_ids":["https://openalex.org/I1328302364"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064525249","display_name":"Blas\u00e9 N. Polite","orcid":"https://orcid.org/0000-0001-8743-8096","observed_orcids":["https://orcid.org/0000-0001-8743-8096"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Blase N. Polite","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090156519","display_name":"Hedy Lee Kindler","orcid":"https://orcid.org/0000-0002-5450-842X","observed_orcids":["https://orcid.org/0000-0002-5450-842X"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hedy L. Kindler","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101836399","display_name":"Manish R. Sharma","orcid":"https://orcid.org/0000-0002-6711-1552","observed_orcids":["https://orcid.org/0000-0002-6711-1552"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Manish Sharma","raw_affiliation_strings":["University of Chicago, Chicago, IL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Chicago, Chicago, IL;","institution_ids":["https://openalex.org/I40347166"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":8,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"e16241","last_page":"e16241"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.5497999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.3801000118255615,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.022700000554323196,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/5-fluorouracil","display_name":"5-fluorouracil","score":0.9259999990463257},{"id":"https://openalex.org/keywords/irinotecan","display_name":"irinotecan","score":1.0},{"id":"https://openalex.org/keywords/nab-paclitaxel","display_name":"nab-paclitaxel","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ugt1a1-genotype","display_name":"UGT1A1 genotype","score":0.7599999904632568},{"id":"https://openalex.org/keywords/genotype-guided-dosing","display_name":"genotype-guided dosing","score":0.8489999771118164},{"id":"https://openalex.org/keywords/sn-38","display_name":"SN-38","score":0.7229999899864197},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.9200000166893005},{"id":"https://openalex.org/keywords/febrile-neutropenia","display_name":"febrile neutropenia","score":0.7960000038146973},{"id":"https://openalex.org/keywords/pancreatic-cancer","display_name":"pancreatic cancer","score":0.9330000281333923},{"id":"https://openalex.org/keywords/biliary-tract-cancer","display_name":"biliary tract cancer","score":0.9980000257492065},{"id":"https://openalex.org/keywords/gastroesophageal-adenocarcinoma","display_name":"gastroesophageal adenocarcinoma","score":0.9700000286102295}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8909632563591003},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.7025095224380493},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6400771141052246},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.6354225873947144},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.6177389621734619},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6068871021270752},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5127397775650024},{"id":"https://openalex.org/C2778850193","wikidata":"https://www.wikidata.org/wiki/Q3775974","display_name":"Febrile neutropenia","level":4,"score":0.5108323097229004},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.4733293652534485},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.4579890966415405},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.4413278102874756},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3600151836872101},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3432596027851105},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3337475061416626},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.16712400317192078},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.1638241708278656}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.e16241","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.e16241","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.75,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2795629919","https://openalex.org/W2983380510","https://openalex.org/W2338822569","https://openalex.org/W2909878524","https://openalex.org/W4205863434","https://openalex.org/W4379282311","https://openalex.org/W3043633835","https://openalex.org/W2598700300","https://openalex.org/W2905911070","https://openalex.org/W2729535064"],"abstract_inverted_index":{"e16241":[0],"Background:":[1],"5-FU,":[2],"IRI,":[3],"and":[4,31,78,99,109,124,233,248,264,314,324],"NP":[5,125],"are":[6,212],"active":[7,22],"in":[8,39,67,239,276,288,308,322,328],"GI":[9,69,76,231,312],"cancers;":[10],"the":[11,21],"combination,":[12],"FOLFIRABRAX,":[13],"has":[14],"not":[15,287,327],"been":[16],"evaluated.":[17],"UGT1A1":[18,96],"clears":[19],"SN-38,":[20],"metabolite":[23],"of":[24,53,58,106,181,191,304],"IRI.":[25,59],"UGT1A1*28":[26],"polymorphism":[27],"reduces":[28],"enzymatic":[29],"activity":[30],"predisposes":[32],"to":[33,166],"severe":[34],"IRI":[35,104,305],"toxicity.":[36,167],"Dose":[37],"adjustment":[38],"pts":[40,101,183,211,293,309],"with":[41,55,73,85,193,202,274,301,310],"this":[42],"allele":[43],"may":[44],"be":[45],"warranted.":[46],"Primary":[47],"endpoint:":[48],"dose-limiting":[49],"toxicity":[50,155,199],"(DLT)":[51],"rate":[52,173],"FOLFIRABRAX":[54,84,300],"genotype-guided":[56,302],"dosing":[57,303],"Secondary":[60],"endpoints":[61],"include":[62],"objective":[63],"response":[64],"rates":[65],"(RR)":[66],"select":[68],"cancers.":[70],"Methods:":[71],"Pts":[72],"previously":[74],"untreated":[75],"cancers":[77,313],"ECOG":[79],"performance":[80],"status":[81],"0/1":[82],"received":[83,102],"prophylactic":[86],"pegfilgrastim":[87],"Q14":[88,131],"days.":[89,132],"CT":[90],"scans":[91],"were":[92,128,169,237,253,320],"obtained":[93],"Q8":[94],"weeks.":[95,298],"*1/*1,":[97],"*1/*28,":[98],"*28/*28":[100,250],"initial":[103],"doses":[105],"180,":[107],"135,":[108],"90":[110],"mg/m2,":[111,123],"respectively.":[112],"5-FU":[113],"2400":[114],"mg/m2":[115,127],"over":[116],"46":[117],"hours":[118],"(no":[119],"bolus),":[120],"leucovorin":[121],"400":[122],"125":[126],"given":[129],"IV":[130],"DLT":[133,172],"during":[134,174],"cycle":[135,175],"1":[136,176,234],"was":[137,177],"defined":[138],"as":[139],"Grade":[140],"(Gr)":[141],"3/4":[142,153],"febrile":[143],"neutropenia":[144,148],"(FN),":[145],"Gr":[146,152,254,259,265],"4":[147,229],"\u2265":[149],"5":[150],"days,":[151],"non-hematologic":[154],"despite":[156],"medical":[157],"management,":[158],"or":[159,204,316],"treatment":[160],"delay":[161],">":[162],"14":[163],"days":[164],"due":[165],"Doses":[168],"tolerable":[170,307],"if":[171],"\u2264":[178],"35%.":[179],"Enrollment":[180],"17":[182],"per":[184],"genotype":[185],"allowed":[186],"for":[187,214],"an":[188],"alpha":[189],"level":[190],"0.05":[192],"80%":[194],"power":[195],"under":[196],"a":[197],"sequential":[198],"monitoring":[200],"procedure,":[201],"6":[203,225],"fewer":[205],"DLTs":[206,236,252],"deemed":[207],"tolerable.":[208],"Results:":[209],"50":[210],"evaluable":[213,279],"toxicity:":[215],"30":[216],"pancreatic":[217],"cancer":[218,223],"(PC),":[219],"9":[220],"biliary":[221],"tract":[222],"(BTC),":[224],"gastroesophageal":[226],"adenocarcinoma":[227],"(GEA),":[228],"unknown":[230],"primary,":[232],"neuroendocrine.":[235],"observed":[238,321],"5/23":[240],"(21.7%)":[241],"*1/*1":[242],"pts,":[243,247,280,284],"1/20":[244],"(5%)":[245],"*1/*28":[246],"0/7":[249],"pts.":[251],"3":[255,260,266],"diarrhea":[256],"(3":[257],"pts),":[258,263],"nausea":[261],"(2":[262],"FN":[267],"(1":[268],"pt).":[269],"RR":[270],"is":[271,306],"12/39":[272],"(30.7%),":[273],"responses":[275],"PC":[277,323],"(9/25":[278],"36%),":[281],"GEA":[282,325],"(3/6":[283],"50%),":[285],"but":[286,326],"BTC":[289],"(0/8":[290],"pts).":[291],"Ten":[292],"continued":[294],"therapy":[295],"beyond":[296],"24":[297],"Conclusions:":[299],"advanced":[311],"UGT1A1*1*1":[315],"UGT1A1*1*28":[317],"genotypes.":[318],"Responses":[319],"BTC.":[329],"Clinical":[330],"trial":[331],"information:":[332],"NCT02333188.":[333]},"counts_by_year":[],"updated_date":"2026-10-13T10:08:12.033832","created_date":"2018-09-27T00:00:00"}